|
Market Closed -
London S.E.
11:35:17 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 63.30 GBX | -1.25% |
|
-5.52% | +9.14% |
| 10-15 | Avacta Group Plc, H1 2026 Earnings Call, Oct 15, 2026 | |
| 10-08 | Equipmake hails "key milestone" for Project Coeus | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 417M | - | ||||
| 63.29B | |||||
| 54.89B | |||||
| 53.28B | |||||
| 45.81B | |||||
| 43.46B |
- Stock Market
- Stocks
- AVCT Stock
- Charts Avacta Group Plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
